Stocks股票 / Health Care / HAE
HAE US listed · USD美股 · 美元
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr.Haemonetics Corporation 是一家全球性的血液和血浆供应与服务提供商,由博士在马萨诸塞州纳蒂克创立。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-09-29Earnings财务业绩
next report下次财报 2026-11-05Estimates being cut预期下调
Beat expectations 4 quarters in a row连续 4 季度超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 6.0%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | HAE | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 50.68x | 29.58 | |
| P/B市净率 | 5.41x | 3.30 | |
| P/S市销率 | 3.70x | 3.19 | |
| Earnings yield盈利收益率 | 1.97% | 2.56 | |
| FCF yield自由现金流收益率 | 5.28% | 4.11 | |
| Shareholder yield股东收益率 | 3.55% | 1.87 | |
| EV/EBITDA企业价值/EBITDA | 22.02x | 18.53 | |
| P/FCF市值/自由现金流 | 18.93x | 21.50 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Debt coming due到期债务
FY2026 10-KIn the 12-month bucket following fiscal period end 2026-03-28, it reported $7.9M due — about 1% of its disclosed principal.在财年期末 2026-03-28 之后12个月的区间内,已披露到期本金为 $7.9M,约占其披露本金的 1%。
All maturity buckets are measured from fiscal period end 2026-03-28, not from today.所有到期区间均从财年期末 2026-03-28 起算,而非从今天起算。
Cash reported at 2026-03-28: $245440000.截至 2026-03-28 披露的现金:$245440000。 Operating cash flow exceeded or equaled equipment spending over 2025-03-30 to 2026-03-28; no cash burn to measure.在 2025-03-30 至 2026-03-28 期间,经营现金流不低于设备支出,无可衡量的现金消耗。
Cash reported at 2026-03-28 covers 3117% of issuer-reported principal in the 12-month bucket following that fiscal period end.截至 2026-03-28 披露的现金可覆盖该财年期末之后12个月区间内发行人已披露到期本金的 3117%。
Cash shortfall against that reported principal: $0相对该已披露本金的现金缺口:$0。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实,不跨文件拼接。文件
0000313143-26-000050, period ending报告期截至 2026-03-28, unit单位 USD.
Cache acquired缓存获取时间: 2026-09-26T08:01:44.434091+00:00.
6/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Annual period年度区间 2025-03-30 — 2026-03-28 · USD · 10-K · 0000313143-26-000050 · Filed提交日期 2026-05-20.
Cache acquired缓存获取时间: 2026-09-26T08:01:44.434091+00:00 · Evaluated as of评估截至 2026-09-30.
- Reported operating cash flow已披露经营活动现金流: $293221000
- Reported equipment spending (capex outflow)已披露设备支出(资本开支流出): $32780000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流(经营现金流减资本开支): $260441000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变,不包括债务偿还、受限现金调整与未来融资。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Signal history信号历史
engine events引擎事件Company profile公司档案
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr.Haemonetics Corporation 是一家全球性的血液和血浆供应与服务提供商,由博士在马萨诸塞州纳蒂克创立。
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 50.7× | 29.6× | 20% |
| Price / Book市净率 | 5.4× | 3.3× | 31% |
| Price / Sales市销率 | 3.7× | 3.2× | 39% |
| EV / EBITDAEV/EBITDA | 22.0× | 18.5× | 37% |
| Earnings yield盈利收益率 | 2.0% | 2.6% | 40% |
| Free-cash-flow yield自由现金流收益率 | 6.0% | 5.5% | 59% |
| Shareholder yield股东综合回报率 | 3.5% | 1.9% | 70% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -2.9% | +1.3% |
| 1 Month近1月 | -1.2% | +0.9% |
| 3 Months近3月 | +36.2% | +6.1% |
| 6 Months近6月 | +94.9% | +22.3% |
| Year to date年初至今 | +31.7% | +13.8% |
| 1 Year近1年 | +120.9% | +18.5% |
| 3 Years近3年 | +19.3% | +87.8% |
Trading information交易信息
Multi-year record多年财务记录
| 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | 20262026 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $870M | $993M | $1.2B | $1.3B | $1.4B | $1.3B |
| EPS每股收益 | $1.55 | $0.84 | $2.24 | $2.29 | $3.31 | $2.05 |
| Free cash flow自由现金流 | $72M | $76M | $163M | $115M | $142M | $260M |
| Gross margin毛利率 | 45.7% | 50.9% | 52.6% | 52.8% | 55.0% | 59.0% |
| Net margin净利率 | 9.1% | 4.4% | 9.9% | 9.0% | 12.3% | 7.3% |
| FCF margin自由现金流利润率 | 8.2% | 7.6% | 13.9% | 8.8% | 10.5% | 19.5% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: gross margin +13.3pts over 6 years定价能力:毛利率 6 年上升 13.3 个百分点
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 3.06 — safe zone资产负债表:Altman Z 3.06——安全区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $1.14 | $1.07 | +6.5% |
| Mar 2026 | $1.29 | $1.28 | +0.8% |
| Dec 2025 | $1.31 | $1.27 | +3.1% |
| Sep 2025 | $1.27 | $1.12 | +13.4% |
Estimate revisions预期修正
Insiders & shorts内部人与空头
Recent fund flows近期基金流向
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 0% | -11.8% | 3 |
| Feb2月 | 0% | -4.2% | 3 |
| Mar3月 | 33% | -2.8% | 3 |
| Apr4月 | 100% | +6.8% | 3 |
| May5月 | 67% | +7.6% | 3 |
| Jun6月 | 67% | +9.8% | 3 |
| Jul7月 | 67% | +8.8% | 3 |
| Aug8月 | 50% | +5.1% | 4 |
| Sep9月 | 75% | +2.3% | 4 |
| Oct10月 | 33% | -4.7% | 3 |
| Nov11月 | 67% | +21.6% | 3 |
| Dec12月 | 33% | -1.2% | 3 |